EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Thymoquinone loaded on chitosan nanoparticles alleviated the consequences of cryptosporidiosis infection in a murine model: Evidence from parasitological, histopathological, immunohistochemical, and immunological studies

Abdelmoneim A Ali, Eman S El-Wakil iD, Al-Sayed R Al-Attar, Mahmoud Fawzy, Aya Samy, Zienab E Eldin, Wafa Abdullah I Al-Megrin, John T Nazeer

PLOS One · 2025

DOI: 10.1371/journal.pone.0325077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Abdelmoneim A Ali und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt. Hauptthemen laut MEDLINE: Chitosan, Nanoparticles, Cryptosporidiosis, Benzoquinones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cryptosporidiosis, a parasitic zoonosis caused by the genus Cryptosporidium ( C. ), currently lacks a vaccine or fully effective treatment. Nitazoxanide (NTZ), the only medication approved by the US Food and Drug Administration for treating cryptosporidiosis, exhibits limited efficacy in immunosuppressed hosts. Thymoquinone (THQ), the active component of Nigella sativa , possesses immunomodulatory, antitumor, hepatoprotective, antioxidant, antimicrobial, and antiprotozoal properties. This study evaluated the therapeutic effects of THQ alone or loaded onto chitosan nanoparticles (CsNPs) against Cryptosporidium parvum infection compared to NTZ.

Methods

Chitosan nanoparticles were synthesized and characterized using X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), zeta potential analysis, and scanning electron microscopy. The cytotoxicity of CsNPs, THQ/CsNPs, and NTZ/CsNPs was evaluated on HT-29 cells. Mice were divided into seven groups to assess treatment efficacy through parasitological analysis of oocyst shedding, histopathological examination of intestinal, hepatic, and splenic tissues, immunohistochemical analysis using cyclin D1 staining of intestinal tissue, and immunological analysis measuring IFN-γ and IL-10 cytokine levels. Additionally, pharmacokinetic profiles of THQ and NTZ in free and nanoparticle-loaded forms were analyzed.

Results

XRD confirmed changes in peak position, shape, and intensity following the loading of THQ and NTZ into CsNPs. FTIR spectra demonstrated distinct differences in peak patterns between loaded nanoparticles and individual components, confirming successful drug encapsulation. Moreover, cytotoxicity studies showed dose-dependent effects on cell viability, with NTZ/CsNPs exhibiting the highest cytotoxicity. Regarding oocyst shedding reduction, THQ demonstrated greater efficacy than NTZ (77% vs. 54%), which was further enhanced when loaded onto CsNPs (89% for THQ/CsNPs vs. 78% for NTZ/CsNPs). Histopathological analysis revealed the restoration of structural alterations in intestinal, hepatic, and splenic tissues in treated groups. Cyclin D1 immunohistochemical staining showed a significant reduction in immunoreactivity in the THQ/CsNP-treated group compared to other treatments. Furthermore, immune responses were modulated by nanoparticle therapies, with significantly lower IFN-γ levels and higher IL-10 levels in treated groups. Pharmacokinetic analysis demonstrated that CsNP formulations significantly improved drug bioavailability by achieving higher peak plasma concentrations ( C max ), earlier time to peak concentration ( T max ), and prolonged half-life ( t 1/2 ) compared to free drugs.

Conclusion

Thymoquinone demonstrated significant potential as an anti-cryptosporidiosis therapeutic agent, with enhanced efficacy when loaded onto chitosan nanoparticles. Chitosan-based nanoparticle formulations improved the pharmacokinetic profiles of both THQ and NTZ, offering a promising strategy for enhancing drug bioavailability and retention while reducing parasitic burden and modulating immune responses effectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChitosanNanoparticlesCryptosporidiosisBenzoquinonesAnimalsMiceHumansHT29 CellsDisease Models, AnimalCryptosporidium parvumFemale

Substanzen

ChitosanthymoquinoneBenzoquinones

Autor:innen und Institutionen

  • Pathology Department, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
  • Department of Parasitology, Theodor Bilharz Research Institute, Giza, Egypt.
  • Materials Science and Nanotechnology Department, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef University, Beni-Suef, Egypt.
  • Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Department of Medical Parasitology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

ORCID-Profile: Eman S El-Wakil

Zitieren

APA

Ali, A. A., El-Wakil, E. S., Al-Attar, A. R., Fawzy, M., Samy, A., Eldin, Z. E., Al-Megrin, W. A. I., & Nazeer, J. T. (2025). Thymoquinone loaded on chitosan nanoparticles alleviated the consequences of cryptosporidiosis infection in a murine model: Evidence from parasitological, histopathological, immunohistochemical, and immunological studies. PLOS One. https://doi.org/10.1371/journal.pone.0325077

Vancouver

Ali AA, El-Wakil ES, Al-Attar AR, Fawzy M, Samy A, Eldin ZE, et al. Thymoquinone loaded on chitosan nanoparticles alleviated the consequences of cryptosporidiosis infection in a murine model: Evidence from parasitological, histopathological, immunohistochemical, and immunological studies. PLOS One. 2025. doi:10.1371/journal.pone.0325077

BibTeX
@article{Ali2025,
  author = {Ali, Abdelmoneim A and El-Wakil, Eman S and Al-Attar, Al-Sayed R and Fawzy, Mahmoud and Samy, Aya and Eldin, Zienab E and Al-Megrin, Wafa Abdullah I and Nazeer, John T},
  title = {Thymoquinone loaded on chitosan nanoparticles alleviated the consequences of cryptosporidiosis infection in a murine model: Evidence from parasitological, histopathological, immunohistochemical, and immunological studies},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0325077}
}
Kostenlos starten →